Cargando…

KRAS p.G12C Mutation in Metastatic Colorectal Cancer: Prognostic Implications and Advancements in Targeted Therapies

SIMPLE SUMMARY: In this review, we aim to clarify the prognostic significance of the KRAS p.G12C mutation in metastatic colorectal cancer, emphasizing its potential as a promising therapeutic target. Moreover, our objective is to increase readers’ awareness of the factors that can influence diverse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ottaiano, Alessandro, Sabbatino, Francesco, Perri, Francesco, Cascella, Marco, Sirica, Roberto, Patrone, Renato, Capuozzo, Maurizio, Savarese, Giovanni, Ianniello, Monica, Petrillo, Nadia, Circelli, Luisa, Granata, Vincenza, Berretta, Massimiliano, Santorsola, Mariachiara, Nasti, Guglielmo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377118/ https://www.ncbi.nlm.nih.gov/pubmed/37509241 http://dx.doi.org/10.3390/cancers15143579

Ejemplares similares

BRAF p.V600E mutation as a molecular boundary between genuine oligo-repeated and poly-metastatic disease in colorectal cancer
por: Ottaiano, Alessandro, et al.
Publicado: (2023)

From Chaos to Opportunity: Decoding Cancer Heterogeneity for Enhanced Treatment Strategies
por: Ottaiano, Alessandro, et al.
Publicado: (2023)

Survival and Toxicities of Metastatic Colorectal Cancer Patients Treated with Regorafenib before TAS-102 or Vice Versa: A Mono-Institutional Real-Practice Study
por: Ottaiano, Alessandro, et al.
Publicado: (2023)

Hypertension, type 2 diabetes, obesity, and p53 mutations negatively correlate with metastatic colorectal cancer patients’ survival
por: Ottaiano, Alessandro, et al.
Publicado: (2023)

Genetic landscape of colorectal cancer patients manifesting tumor shrinkage during SARS-Cov-2 infection
por: Ottaiano, Alessandro, et al.
Publicado: (2022)

Metastatic colorectal cancer and type 2 diabetes: prognostic and genetic interactions
por: Ottaiano, Alessandro, et al.
Publicado: (2021)

Evolution of Treatment in Advanced Cholangiocarcinoma: Old and New towards Precision Oncology
por: Capuozzo, Maurizio, et al.
Publicado: (2022)

p53: From Fundamental Biology to Clinical Applications in Cancer
por: Capuozzo, Maurizio, et al.
Publicado: (2022)

Characterization of KRAS Mutational Regression in Oligometastatic Patients
por: Ottaiano, Alessandro, et al.
Publicado: (2022)

Tumour Burden Reporting in Phase III Clinical Trials of Metastatic Lung, Breast, and Colorectal Cancers: A Systematic Review
por: Santorsola, Mariachiara, et al.
Publicado: (2022)

Clinical and Molecular Characteristics of Rare Malignant Tumors of Colon and Rectum
por: Ottaiano, Alessandro, et al.
Publicado: (2022)

Oligo-Metastatic Cancers: Putative Biomarkers, Emerging Challenges and New Perspectives
por: Ottaiano, Alessandro, et al.
Publicado: (2023)

KRAS Mutational Regression Is Associated With Oligo-Metastatic Status and Good Prognosis in Metastatic Colorectal Cancer
por: Ottaiano, Alessandro, et al.
Publicado: (2021)

Genetic regressive trajectories in colorectal cancer: A new hallmark of oligo-metastatic disease?
por: Ottaiano, Alessandro, et al.
Publicado: (2021)

Prognostic Significance of CXCR4 in Colorectal Cancer: An Updated Meta-Analysis and Critical Appraisal
por: Ottaiano, Alessandro, et al.
Publicado: (2021)

Evolution of Mutational Landscape and Tumor Immune-Microenvironment in Liver Oligo-Metastatic Colorectal Cancer
por: Ottaiano, Alessandro, et al.
Publicado: (2020)

Minimally invasive surgical treatment of intrahepatic cholangiocarcinoma: A systematic review
por: Patrone, Renato, et al.
Publicado: (2021)

A New Source of Heterogeneity in Comparative and Translational Clinical Trials: The “Border-Time” Bias
por: Santorsola, Mariachiara, et al.
Publicado: (2022)

Circulating Tumor Cells as Predictive and Prognostic Biomarkers in Solid Tumors
por: Capuozzo, Maurizio, et al.
Publicado: (2023)

Multifaceted Insights into Innovative Approaches to Treating Colorectal Cancer Metastasis: From Emerging Biological Factors to Radiomics
por: Ottaiano, Alessandro, et al.
Publicado: (2023)

Circulating Vitamin D Level and Its Impact on Mortality and Recurrence in Stage III Colorectal Cancer Patients: A Systematic Review and Meta-Analysis
por: Ottaiano, Alessandro, et al.
Publicado: (2023)

Colorectal liver metastases patients prognostic assessment: prospects and limits of radiomics and radiogenomics
por: Granata, Vincenza, et al.
Publicado: (2023)

Correction: Colorectal liver metastases patients prognostic assessment: prospects and limits of radiomics and radiogenomics
por: Granata, Vincenza, et al.
Publicado: (2023)

Cancer Cell Metabolism Reprogramming and Its Potential Implications on Therapy in Squamous Cell Carcinoma of the Head and Neck: A Review
por: Perri, Francesco, et al.
Publicado: (2022)

Non-invasive prenatal testing can detect silent cancers in expecting mothers
por: Ottaiano, Alessandro, et al.
Publicado: (2023)

Unexpected tumor reduction in metastatic colorectal cancer patients during SARS-Cov-2 infection
por: Ottaiano, Alessandro, et al.
Publicado: (2021)

COVID-19 Outbreak: The North versus South Epidemiologic Italian Paradigm
por: Ottaiano, Alessandro, et al.
Publicado: (2021)

Prior Anti-Angiogenic TKI-Based Treatment as Potential Predisposing Factor to Nivolumab-Mediated Recurrent Thyroid Disorder Adverse Events in mRCC Patients: A Case Series
por: Liguori, Luigi, et al.
Publicado: (2023)

Can the addition of radiotherapy postoperatively increase clinical outcome of patients with gastric cancer? A systematic review of the literature and meta-analysis
por: Fiorica, Francesco, et al.
Publicado: (2017)

Conventional, functional and radiomics assessment for intrahepatic cholangiocarcinoma
por: Granata, Vincenza, et al.
Publicado: (2022)

Correction: Conventional, functional and radiomics assessment for intrahepatic cholangiocarcinoma
por: Granata, Vincenza, et al.
Publicado: (2022)

The safety and efficacy of Glubran 2 as biliostatic agent in liver resection
por: Patrone, Renato, et al.
Publicado: (2021)

Prospective Evaluation of Radiotherapy-Induced Immunologic and Genetic Effects in Colorectal Cancer Oligo-Metastatic Patients with Lung-Limited Disease: The PRELUDE-1 Study
por: Ottaiano, Alessandro, et al.
Publicado: (2021)

Artificial Intelligence for Automatic Pain Assessment: Research Methods and Perspectives
por: Cascella, Marco, et al.
Publicado: (2023)

A Multicenter Randomized Controlled Prospective Study to Assess Efficacy of Laparoscopic Electrochemotherapy in the Treatment of Locally Advanced Pancreatic Cancer
por: Izzo, Francesco, et al.
Publicado: (2021)

Prediction of response to anti-EGFR antibodies in metastatic colorectal cancer: looking beyond EGFR inhibition
por: Ottaiano, Alessandro, et al.
Publicado: (2013)

Computational Analysis of KRAS Mutations: Implications for Different Effects on the KRAS p.G12D and p.G13D Mutations
por: Chen, Chih-Chieh, et al.
Publicado: (2013)

Aflibercept or bevacizumab in combination with FOLFIRI as second-line treatment of mRAS metastatic colorectal cancer patients: the ARBITRATION study protocol
por: Ottaiano, Alessandro, et al.
Publicado: (2021)

Early Assessment of Colorectal Cancer Patients with Liver Metastases Treated with Antiangiogenic Drugs: The Role of Intravoxel Incoherent Motion in Diffusion-Weighted Imaging
por: Granata, Vincenza, et al.
Publicado: (2015)

Qualitative assessment of EOB-GD-DTPA and Gd-BT-DO3A MR contrast studies in HCC patients and colorectal liver metastases
por: Granata, Vincenza, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_iecq10smsr4e37atdk7avphk5b